Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 81; no. 2; pp. 599 - 612
Main Authors Mehandru, Saurabh, Poles, Michael A, Tenner-Racz, Klara, Manuelli, Victoria, Jean-Pierre, Patrick, Lopez, Peter, Shet, Anita, Low, Andrea, Mohri, Hiroshi, Boden, Daniel, Racz, Paul, Markowitz, Martin
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.01.2007
Subjects
Online AccessGet full text
ISSN0022-538X
1098-5514
DOI10.1128/JVI.01739-06

Cover

Loading…
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4+ T cells are preferentially depleted from the gastrointestinal (GI) lamina propria. To better understand the underlying mechanisms, we studied virological and immunological events within the peripheral blood (PB) and GI tract during AEI. A total of 32 AEI subjects and 18 uninfected controls underwent colonic biopsy. HIV-1 viral DNA and RNA levels were quantified in CD4+ T cells derived from the GI tract and PB by using real-time PCR. The phenotype of infected cells was characterized by using combinations of immunohistochemistry and in situ hybridization. Markers of immunological memory, activation, and proliferation were examined by flow cytometry and immunohistochemistry, and the host-derived cytotoxic cellular response was examined by using immunohistochemistry. GI CD4+ T cells harbored, on average, 13-fold higher HIV-1 viral DNA levels and 10-fold higher HIV-1 RNA levels than PB CD4+ T cells during AEI. HIV-1 RNA was detected in both "activated" and "nonactivated" mucosal CD4+ T cells. A significantly higher number of activated and proliferating T cells were detected in the GI tract compared to the PB, and a robust cytotoxic response (HIV-1 specificity not determined) was detected in the GI tract as early as 18 days postinfection. Mucosal CD4+ T-cell depletion is multifactorial. Direct viral infection likely accounts for the earliest loss of CD4+ T cells. Subsequently, ongoing infection of susceptible CD4+ T cells, along with activation-induced cellular death and host cytotoxic cellular response, are responsible for the persistence of the lesion.During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4+ T cells are preferentially depleted from the gastrointestinal (GI) lamina propria. To better understand the underlying mechanisms, we studied virological and immunological events within the peripheral blood (PB) and GI tract during AEI. A total of 32 AEI subjects and 18 uninfected controls underwent colonic biopsy. HIV-1 viral DNA and RNA levels were quantified in CD4+ T cells derived from the GI tract and PB by using real-time PCR. The phenotype of infected cells was characterized by using combinations of immunohistochemistry and in situ hybridization. Markers of immunological memory, activation, and proliferation were examined by flow cytometry and immunohistochemistry, and the host-derived cytotoxic cellular response was examined by using immunohistochemistry. GI CD4+ T cells harbored, on average, 13-fold higher HIV-1 viral DNA levels and 10-fold higher HIV-1 RNA levels than PB CD4+ T cells during AEI. HIV-1 RNA was detected in both "activated" and "nonactivated" mucosal CD4+ T cells. A significantly higher number of activated and proliferating T cells were detected in the GI tract compared to the PB, and a robust cytotoxic response (HIV-1 specificity not determined) was detected in the GI tract as early as 18 days postinfection. Mucosal CD4+ T-cell depletion is multifactorial. Direct viral infection likely accounts for the earliest loss of CD4+ T cells. Subsequently, ongoing infection of susceptible CD4+ T cells, along with activation-induced cellular death and host cytotoxic cellular response, are responsible for the persistence of the lesion.
During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4 + T cells are preferentially depleted from the gastrointestinal (GI) lamina propria. To better understand the underlying mechanisms, we studied virological and immunological events within the peripheral blood (PB) and GI tract during AEI. A total of 32 AEI subjects and 18 uninfected controls underwent colonic biopsy. HIV-1 viral DNA and RNA levels were quantified in CD4 + T cells derived from the GI tract and PB by using real-time PCR. The phenotype of infected cells was characterized by using combinations of immunohistochemistry and in situ hybridization. Markers of immunological memory, activation, and proliferation were examined by flow cytometry and immunohistochemistry, and the host-derived cytotoxic cellular response was examined by using immunohistochemistry. GI CD4 + T cells harbored, on average, 13-fold higher HIV-1 viral DNA levels and 10-fold higher HIV-1 RNA levels than PB CD4 + T cells during AEI. HIV-1 RNA was detected in both “activated” and “nonactivated” mucosal CD4 + T cells. A significantly higher number of activated and proliferating T cells were detected in the GI tract compared to the PB, and a robust cytotoxic response (HIV-1 specificity not determined) was detected in the GI tract as early as 18 days postinfection. Mucosal CD4 + T-cell depletion is multifactorial. Direct viral infection likely accounts for the earliest loss of CD4 + T cells. Subsequently, ongoing infection of susceptible CD4 + T cells, along with activation-induced cellular death and host cytotoxic cellular response, are responsible for the persistence of the lesion.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4+ T cells are preferentially depleted from the gastrointestinal (GI) lamina propria. To better understand the underlying mechanisms, we studied virological and immunological events within the peripheral blood (PB) and GI tract during AEI. A total of 32 AEI subjects and 18 uninfected controls underwent colonic biopsy. HIV-1 viral DNA and RNA levels were quantified in CD4+ T cells derived from the GI tract and PB by using real-time PCR. The phenotype of infected cells was characterized by using combinations of immunohistochemistry and in situ hybridization. Markers of immunological memory, activation, and proliferation were examined by flow cytometry and immunohistochemistry, and the host-derived cytotoxic cellular response was examined by using immunohistochemistry. GI CD4+ T cells harbored, on average, 13-fold higher HIV-1 viral DNA levels and 10-fold higher HIV-1 RNA levels than PB CD4+ T cells during AEI. HIV-1 RNA was detected in both "activated" and "nonactivated" mucosal CD4+ T cells. A significantly higher number of activated and proliferating T cells were detected in the GI tract compared to the PB, and a robust cytotoxic response (HIV-1 specificity not determined) was detected in the GI tract as early as 18 days postinfection. Mucosal CD4+ T-cell depletion is multifactorial. Direct viral infection likely accounts for the earliest loss of CD4+ T cells. Subsequently, ongoing infection of susceptible CD4+ T cells, along with activation-induced cellular death and host cytotoxic cellular response, are responsible for the persistence of the lesion.
Author Anita Shet
Peter Lopez
Michael A. Poles
Andrea Low
Victoria Manuelli
Patrick Jean-Pierre
Saurabh Mehandru
Martin Markowitz
Hiroshi Mohri
Paul Racz
Klara Tenner-Racz
Daniel Boden
AuthorAffiliation Aaron Diamond AIDS Research Center and Rockefeller University, New York, New York 10016, 1 New York University School of Medicine, Department of Medicine, Division of Gastroenterology, New York, New York 10016, 2 Bernhard-Nocht Institut für Tropenmedizin, 20359 Hamburg, Germany 3
AuthorAffiliation_xml – name: Aaron Diamond AIDS Research Center and Rockefeller University, New York, New York 10016, 1 New York University School of Medicine, Department of Medicine, Division of Gastroenterology, New York, New York 10016, 2 Bernhard-Nocht Institut für Tropenmedizin, 20359 Hamburg, Germany 3
Author_xml – sequence: 1
  givenname: Saurabh
  surname: Mehandru
  fullname: Mehandru, Saurabh
  organization: Aaron Diamond AIDS Research Center, Rockefeller University, 455 First Ave., 7th Fl., New York, NY 10016, USA
– sequence: 2
  givenname: Michael A
  surname: Poles
  fullname: Poles, Michael A
– sequence: 3
  givenname: Klara
  surname: Tenner-Racz
  fullname: Tenner-Racz, Klara
– sequence: 4
  givenname: Victoria
  surname: Manuelli
  fullname: Manuelli, Victoria
– sequence: 5
  givenname: Patrick
  surname: Jean-Pierre
  fullname: Jean-Pierre, Patrick
– sequence: 6
  givenname: Peter
  surname: Lopez
  fullname: Lopez, Peter
– sequence: 7
  givenname: Anita
  surname: Shet
  fullname: Shet, Anita
– sequence: 8
  givenname: Andrea
  surname: Low
  fullname: Low, Andrea
– sequence: 9
  givenname: Hiroshi
  surname: Mohri
  fullname: Mohri, Hiroshi
– sequence: 10
  givenname: Daniel
  surname: Boden
  fullname: Boden, Daniel
– sequence: 11
  givenname: Paul
  surname: Racz
  fullname: Racz, Paul
– sequence: 12
  givenname: Martin
  surname: Markowitz
  fullname: Markowitz, Martin
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18615277$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17065209$$D View this record in MEDLINE/PubMed
BookMark eNpVkEtv1DAURi1URKeFHWvkDWxQih9x7GyQqulrUBGboWJn3Tg3E1eJM9hJUf59U3V4re7iHp0jfSfkKAwBCXnL2Rnnwnz6crc5Y1zLMmPFC7LirDSZUjw_IivGhMiUND-OyUlK94zxPC_yV-SYa1YowcoVmb-iayH41Cc6NPQa0hgHH0ZMow_Q0fVF_pFuszV2Hb3AfYejHwKtp-jDjp67aUQKoaaXELuZ3kw9BLrp-ykMNTbeeQxupnc-Tolu5z1STjehQfckeU1eNtAlfHO4p-T71eV2fZPdfrverM9vs1bycsxyVgByaIyspGJ1o6WqKqh1jcJVQjaa8YpzpcDkFZii1FUthXLMoXFKNbU8JZ-fvfup6rF2GMYInd1H30Oc7QDe_v8JvrW74cFyXeq80Ivgw0EQh5_TMoztfXLLIBBwmJItjDS5KPkCvvu39Cfxe-0FeH8AIDnomgjB-fSXMwVXQj8V6TPX-l37y0e0kHp7_-Ct4VZYVZbyESG5nQk
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright © 2007, American Society for Microbiology 2007
Copyright_xml – notice: 2007 INIST-CNRS
– notice: Copyright © 2007, American Society for Microbiology 2007
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1128/JVI.01739-06
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 612
ExternalDocumentID PMC1797467
17065209
18615277
jvi_81_2_599
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U01 AI041534
– fundername: NIAID NIH HHS
  grantid: AI-41534
– fundername: NCRR NIH HHS
  grantid: M01 RR000102
– fundername: NCRR NIH HHS
  grantid: M01-RR00102
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAFWJ
AAGFI
AAYJJ
ABPPZ
ACGFO
ACNCT
ADBBV
ADXHL
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
D0S
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
IQODW
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
PKN
RHF
UCJ
7X8
5PM
ID FETCH-LOGICAL-h319t-406ae1af83b350df735bbad7de2cb23f701b1155a84ba8697bd325c0ce8c55fd3
ISSN 0022-538X
IngestDate Thu Aug 21 13:37:15 EDT 2025
Thu Jul 10 19:15:40 EDT 2025
Wed Feb 19 01:45:19 EST 2025
Mon Jul 21 09:14:22 EDT 2025
Wed May 18 15:32:41 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Immunopathology
HIV-1 virus
Acute
Retroviridae
AIDS
Immune deficiency
Lentivirus
Mechanism
Virology
Infection
Virus
Viral disease
T-Lymphocyte
Human immunodeficiency virus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h319t-406ae1af83b350df735bbad7de2cb23f701b1155a84ba8697bd325c0ce8c55fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Aaron Diamond AIDS Research Center, The Rockefeller University, 455 First Ave., 7th Fl., New York, NY 10016. Phone: (212) 448-5020. Fax: (212) 725-1126. E-mail: mmarkowitz@adarc.org.
PMID 17065209
PQID 68384291
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1797467
pascalfrancis_primary_18615277
pubmed_primary_17065209
highwire_asm_jvi_81_2_599
proquest_miscellaneous_68384291
PublicationCentury 2000
PublicationDate 2007-01-01
PublicationDateYYYYMMDD 2007-01-01
PublicationDate_xml – month: 01
  year: 2007
  text: 2007-01-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2007
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References 11095734 - Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13778-83
14557656 - J Virol. 2003 Nov;77(21):11708-17
2217206 - Proc Natl Acad Sci U S A. 1990 Oct;87(19):7727-31
1955708 - J Infect Dis. 1991 Dec;164(6):1051-7
8207839 - J Virol. 1994 Jul;68(7):4650-5
12960820 - AIDS. 2003 Sep 5;17(13):1881-8
10449281 - AIDS. 1999 Jul 30;13(11):1295-303
11507184 - J Virol. 2001 Sep;75(18):8390-9
1383328 - J Immunol. 1992 Oct 15;149(8):2816-22
10805798 - Proc Natl Acad Sci U S A. 2000 May 9;97(10):5393-8
15365095 - J Exp Med. 2004 Sep 20;200(6):761-70
11752159 - J Virol. 2002 Jan;76(2):688-96
15793563 - Nature. 2005 Apr 28;434(7037):1093-7
2893081 - Lancet. 1988 Feb 6;1(8580):259-62
15210827 - J Immunol. 2004 Jul 1;173(1):641-8
1928302 - Am J Pathol. 1991 Oct;139(4):823-30
15793562 - Nature. 2005 Apr 28;434(7037):1148-52
14970317 - Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3017-22
7477265 - Nature. 1995 Oct 26;377(6551):740-4
8599114 - Science. 1996 Mar 15;271(5255):1582-6
16501118 - J Virol. 2006 Mar;80(6):3083-7
9660362 - JAMA. 1998 Jul 1;280(1):42-8
9545219 - Science. 1998 Apr 17;280(5362):427-31
9468362 - AIDS. 1998 Jan 22;12(2):139-46
11017098 - Nat Immunol. 2000 Oct;1(4):285-9
15365096 - J Exp Med. 2004 Sep 20;200(6):749-59
7931086 - J Exp Med. 1994 Oct 1;180(4):1541-6
12001057 - J Infect Dis. 2002 May 1;185(9):1355-8
12193696 - J Immunol. 2002 Sep 1;169(5):2313-22
9500797 - J Exp Med. 1998 Mar 16;187(6):949-59
References_xml – reference: 8207839 - J Virol. 1994 Jul;68(7):4650-5
– reference: 9660362 - JAMA. 1998 Jul 1;280(1):42-8
– reference: 10449281 - AIDS. 1999 Jul 30;13(11):1295-303
– reference: 15793562 - Nature. 2005 Apr 28;434(7037):1148-52
– reference: 8599114 - Science. 1996 Mar 15;271(5255):1582-6
– reference: 12193696 - J Immunol. 2002 Sep 1;169(5):2313-22
– reference: 11752159 - J Virol. 2002 Jan;76(2):688-96
– reference: 15365096 - J Exp Med. 2004 Sep 20;200(6):749-59
– reference: 7477265 - Nature. 1995 Oct 26;377(6551):740-4
– reference: 12001057 - J Infect Dis. 2002 May 1;185(9):1355-8
– reference: 2217206 - Proc Natl Acad Sci U S A. 1990 Oct;87(19):7727-31
– reference: 11507184 - J Virol. 2001 Sep;75(18):8390-9
– reference: 16501118 - J Virol. 2006 Mar;80(6):3083-7
– reference: 9500797 - J Exp Med. 1998 Mar 16;187(6):949-59
– reference: 11095734 - Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13778-83
– reference: 9545219 - Science. 1998 Apr 17;280(5362):427-31
– reference: 10805798 - Proc Natl Acad Sci U S A. 2000 May 9;97(10):5393-8
– reference: 11017098 - Nat Immunol. 2000 Oct;1(4):285-9
– reference: 15793563 - Nature. 2005 Apr 28;434(7037):1093-7
– reference: 14970317 - Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3017-22
– reference: 1955708 - J Infect Dis. 1991 Dec;164(6):1051-7
– reference: 15210827 - J Immunol. 2004 Jul 1;173(1):641-8
– reference: 9468362 - AIDS. 1998 Jan 22;12(2):139-46
– reference: 1383328 - J Immunol. 1992 Oct 15;149(8):2816-22
– reference: 14557656 - J Virol. 2003 Nov;77(21):11708-17
– reference: 1928302 - Am J Pathol. 1991 Oct;139(4):823-30
– reference: 2893081 - Lancet. 1988 Feb 6;1(8580):259-62
– reference: 7931086 - J Exp Med. 1994 Oct 1;180(4):1541-6
– reference: 15365095 - J Exp Med. 2004 Sep 20;200(6):761-70
– reference: 12960820 - AIDS. 2003 Sep 5;17(13):1881-8
SSID ssj0014464
Score 2.3077507
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4+ T cells are preferentially depleted from the...
During acute and early human immunodeficiency virus type 1 (HIV-1) infection (AEI) more than 50% of CD4 + T cells are preferentially depleted from the...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 599
SubjectTerms Acute Disease
Biological and medical sciences
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes - cytology
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - virology
Cytotoxicity, Immunologic
DNA, Viral - blood
Female
Flow Cytometry
Fundamental and applied biological sciences. Psychology
Gastrointestinal Tract - immunology
Gastrointestinal Tract - virology
HIV Infections - immunology
HIV Infections - virology
HIV-1 - isolation & purification
HIV-1 - pathogenicity
Human viral diseases
Humans
Immunohistochemistry
Immunologic Memory
Infectious diseases
Leukocytes, Mononuclear - immunology
Leukocytes, Mononuclear - virology
Lymphocyte Activation
Male
Medical sciences
Microbiology
Miscellaneous
RNA, Viral - blood
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral Load
Virology
Virus-Cell Interactions
Title Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection
URI http://jvi.asm.org/content/81/2/599.abstract
https://www.ncbi.nlm.nih.gov/pubmed/17065209
https://www.proquest.com/docview/68384291
https://pubmed.ncbi.nlm.nih.gov/PMC1797467
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JjtNAEG2FQUhcEDtmGfoAJ8sh3p1jyMAsKBwgE-Vmdbe7FSPFiewYaeY3-SGq3N4SBgRcoshx7MT1XFVdfvWKkDcyxOo-lxZEj9DywP9ZEMfHlqc4FyPu-0pVBNnPwdmld7H0l4PBjx5rqdzxobi-sa_kf6wK28Cu2CX7D5ZtDwob4D3YF17BwvD6VzaeSezbTYt1xcc4ZcUu36D-A9y2mGROT7y3zntzbk2xQHcityi0DdauWxMnAjkCWDjXKse6nn-ODSObRKKyRNWWuUjzsjBxvWra4E40dyv7TVILO-_V6b-yMmd8Zc4kVujzsrWvZuubkyEy8Doe4ydYaDNzjt4_t74wcd18sEjx6ULKkK9ToojoXrkiPChXtM-h-qTUWdqJTvWdNa6T3WryMIQq7Z9R_hSTvL4D1zNfaqA6PW_s69lLv0YJBzsfLhbnQ_BHLqow9HcDG2_XFWJQWghpQl2sbPgBByG0JTZ--57GkR07MZz6FrntwNoFx2qcLlveEa6_vUbCHv9d043hRO_6vwjVbOvT97SrkbrLCrh7lR67ctO66JDe28uX5vfJvRoTdKJR-4AMZPaQ3NGjT68ekasOu3Sj6CF2KWDXpBq5tEUu1cilFXIpAIpWyKUVcukhcmmFXIrIpTZtkfuYXH78MJ-eWfUYEGsF8WFnQcrJpM1U5HLXHyUqdH3OWRIm0hHccRV4Gw7rGp9FHmdRMA554jq-GAkZCfA1ifuEHGWbTD4jVHBI2JXijpKeJ4JxFEiH-TazPQHH82yDGM2VjlmxjvvmNMjx3qWPt1oOJrajAGdDhwZ53dgiBh-ND95YJjdlEQeRG0HeB4d_qi3Tfbc2sUHCPZu1O6D6-_4nWbqqVOAhkuKooOd_-MkvyN3uFnxJjnZ5KV9BDr3jxxUmfwIj_c3M
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+of+Gastrointestinal+CD4%2B+T-Cell+Depletion+during+Acute+and+Early+Human+Immunodeficiency+Virus+Type+1+Infection&rft.jtitle=Journal+of+Virology&rft.au=Saurabh+Mehandru&rft.au=Michael+A.+Poles&rft.au=Klara+Tenner-Racz&rft.au=Victoria+Manuelli&rft.date=2007-01-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=81&rft.issue=2&rft.spage=599&rft_id=info:doi/10.1128%2FJVI.01739-06&rft_id=info%3Apmid%2F17065209&rft.externalDBID=n%2Fa&rft.externalDocID=jvi_81_2_599
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon